| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
586 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
862 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618957 |
Perfluoroalkyl-containing complexes, process for their production as well as their use |
Nov. 17, 2009 |
| 7615548 |
Method to inhibit ischemia and reperfusion injury |
Nov. 10, 2009 |
| 7612082 |
Prostaglandin EP.sub.4 antagonists |
Nov. 3, 2009 |
| 7612056 |
Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists |
Nov. 3, 2009 |
| 7612055 |
Macrocyclic lactams and pharmaceutical use thereof |
Nov. 3, 2009 |
| 7612054 |
Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
Nov. 3, 2009 |
| 7608613 |
Analogs of benzoquinone-containing ansamycins and methods of use thereof |
Oct. 27, 2009 |
| 7608612 |
Radiosensitizer formulations and methods for use |
Oct. 27, 2009 |
| 7608611 |
Hsp90 inhibitors, methods of making and uses therefor |
Oct. 27, 2009 |
| 7601709 |
Macrocyclic hepatitis C serine protease inhibitors |
Oct. 13, 2009 |
| 7598253 |
Reverse-turn mimetics and methods relating thereto |
Oct. 6, 2009 |
| 7595310 |
Glucuronate salt of a piperazine compound |
Sep. 29, 2009 |
| 7592331 |
Macrocyclic factor VIIa inhibitors useful as anticoagulants |
Sep. 22, 2009 |
| 7592330 |
Methods and compositions for preserving the viability of photoreceptor cells |
Sep. 22, 2009 |
| 7589083 |
Compounds and compositions to control abnormal cell growth |
Sep. 15, 2009 |
| 7585839 |
Medical uses of intercellular communication facilitating compounds |
Sep. 8, 2009 |
| 7582664 |
Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
Sep. 1, 2009 |
| 7579337 |
Analogs of benzoquinone-containing ansamycins and methods of use thereof |
Aug. 25, 2009 |
| 7579336 |
Pharmaceutical composition comprising temozolomide ester |
Aug. 25, 2009 |
| 7579334 |
Compounds with anti-inflammatory activity |
Aug. 25, 2009 |
| 7579324 |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
Aug. 25, 2009 |
| 7576074 |
Receptor-type kinase modulators and methods of use |
Aug. 18, 2009 |
| 7576062 |
Compounds with growth hormone releasing properties |
Aug. 18, 2009 |
| 7572798 |
Combi-molecules having signal transduction inhibitory properties and DNA damaging properties |
Aug. 11, 2009 |
| 7566706 |
Analogs of benzoquinone-containing ansamycins and methods of use thereof |
Jul. 28, 2009 |
| 7560449 |
Methods and therapeutic combinations for the treatment of demyelination |
Jul. 14, 2009 |
| 7556931 |
Furosemide modulators of HM74 |
Jul. 7, 2009 |
| 7553832 |
Methods and compositions for specific inhibition of protein splicing by small molecules |
Jun. 30, 2009 |
| 7553831 |
Compounds to treat Alzheimer's disease |
Jun. 30, 2009 |
| 7547688 |
Methods for treatment of nocturia |
Jun. 16, 2009 |
| 7544675 |
Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
Jun. 9, 2009 |
| 7538114 |
Glycine transporter-1 inhibitors |
May. 26, 2009 |
| 7531529 |
Imidazole derivatives |
May. 12, 2009 |
| 7528124 |
1,3-dihydro-2H-indol-2-one derivative |
May. 5, 2009 |
| 7524837 |
Benzotriazapinone salts and methods for using same |
Apr. 28, 2009 |
| 7514442 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
Apr. 7, 2009 |
| 7511064 |
Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT.sub.2B receptor antagonist |
Mar. 31, 2009 |
| 7507727 |
Substituted quinobenzoxazine analogs and methods of using thereof |
Mar. 24, 2009 |
| 7507726 |
Peptide deformylase inhibitors |
Mar. 24, 2009 |
| 7498359 |
Composition and method for preventing recurrence of stroke |
Mar. 3, 2009 |
| 7494986 |
Cycloalkylamine derivatives as NK-1/SSRI antagonists |
Feb. 24, 2009 |
| 7485631 |
Phorboxazole compounds and methods of their preparation |
Feb. 3, 2009 |
| 7485630 |
Neuroprotective macrocyclic compounds and methods for their use |
Feb. 3, 2009 |
| 7479498 |
Treatments for viral infections |
Jan. 20, 2009 |
| 7470715 |
Estrogen modulators |
Dec. 30, 2008 |
| 7470695 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Dec. 30, 2008 |
| 7468372 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
Dec. 23, 2008 |
| 7468363 |
Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
Dec. 23, 2008 |
| 7465747 |
Fluorescent label compounds |
Dec. 16, 2008 |
| 7465718 |
Ansamycins having improved pharmacological and biological properties |
Dec. 16, 2008 |
|
|
|
